Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postinfectious irritable bowel syndrome.

Andrew W DuPont1

  • 1University of Texas Medical Branch, Galveston, TX 77555-0764, USA. awdupont@utmb.edu.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|January 22, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbiota restoration therapies for recurrent <i>Clostridioides difficile</i> infection reach an important new milestone.

Therapeutic advances in gastroenterology·2024
Same author

Incomplete Intestinal Metaplasia of the Stomach Is more Related to Bile Reflux than Chronic Gastritis.

Annals of clinical and laboratory science·2023
Same author

Fecal microbiota transplantation in Parkinson's disease-A randomized repeat-dose, placebo-controlled clinical pilot study.

Frontiers in neurology·2023
Same author

Colonic Eosinophilia: Clinicopathologic Study of Paired Right and Left Colon Biopsies from 276 Patients.

Annals of clinical and laboratory science·2023
Same author

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation.

Microorganisms·2023
Same author

The Quick Sepsis-Related Organ Failure Assessment Score Is Prognostic of Pancreatitis Severity in Patients With Alcohol-Induced Pancreatitis.

Pancreas·2022
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Post-infectious irritable bowel syndrome (PI-IBS) can develop after bacterial gastroenteritis, causing chronic gut issues due to immune system changes. Risk factors include psychological disorders and infection duration, with ongoing research into preventative treatments.

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • Acute bacterial gastroenteritis affects up to one-third of patients with prolonged gastrointestinal complaints.
  • A subset of these patients meet diagnostic criteria for postinfectious irritable bowel syndrome (PI-IBS).
  • PI-IBS is characterized by chronic mucosal immunologic dysregulation, altered intestinal permeability, and motility post-infection.

Purpose of the Study:

  • To explore the pathophysiology of postinfectious irritable bowel syndrome.
  • To identify risk factors associated with the development of PI-IBS.
  • To review current and potential future treatment strategies for PI-IBS.

Main Methods:

  • Review of existing literature on bacterial gastroenteritis and its sequelae.

Related Experiment Videos

  • Analysis of host- and pathogen-related factors contributing to PI-IBS development.
  • Examination of current therapeutic approaches and ongoing research for PI-IBS.

    • Main Results:

    • Post-infectious irritable bowel syndrome involves chronic immune dysregulation, altered gut barrier function, and motility disturbances.
    • Preexisting psychological disorders and longer initial infection duration are linked to increased PI-IBS risk.
    • Current treatments are primarily symptomatic, with research exploring infection prevention and duration reduction.

    Conclusions:

    • Postinfectious irritable bowel syndrome represents a distinct clinical entity following acute gastroenteritis.
    • Understanding risk factors is crucial for targeted prevention and management strategies.
    • Further research into novel therapies, including those targeting the initial infection, is warranted.